Parkinson Clinical Trials in New York, New York
23 recruitingNew York, New York
Showing 1–20 of 23 trials
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
Parkinsons Disease (PD)
BlueRock Therapeutics102 enrolled39 locationsNCT06944522
Recruiting
Phase 2Phase 3
A Study of Buntanetap in Participants With PD
Deep Brain StimulationParkinson's Disease (PD)
Annovis Bio Inc.500 enrolled27 locationsNCT07284784
Recruiting
Phase 2
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Parkinson DiseaseParkinsonParkinson Disease, Idiopathic+2 more
Neuron23 Inc.150 enrolled70 locationsNCT06680830
Recruiting
Not Applicable
Study in Parkinson Disease of Exercise
Parkinson Disease
Northwestern University370 enrolled25 locationsNCT04284436
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Parkinson's Disease
Hoffmann-La Roche900 enrolled101 locationsNCT07174310
Recruiting
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
Michael J. Fox Foundation for Parkinson's Research4,500 enrolled50 locationsNCT04477785
Recruiting
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Movement DisordersParkinsons DiseaseNeurology
InSightec60 enrolled5 locationsNCT05539196
Recruiting
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
Tremor Associated With Tremor Dominant Parkinson's Disease
InSightec50 enrolled8 locationsNCT04991831
Recruiting
Phase 1
This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.
Parkinson Disease
iRegene Therapeutics Co., Ltd.5 enrolled1 locationNCT07102342
Recruiting
Phase 1Phase 2
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
Parkinson's Disease
Sumitomo Pharma America, Inc.25 enrolled2 locationsNCT06753331
Recruiting
Phase 2
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)
Parkinson Disease
Denali Therapeutics Inc.50 enrolled20 locationsNCT06602193
Recruiting
Phase 2Phase 3
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Parkinson Disease
Biohaven Therapeutics Ltd.550 enrolled15 locationsNCT06976268
Recruiting
Phase 3
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
Parkinson Disease
Cerevance330 enrolled49 locationsNCT06553027
Recruiting
Not Applicable
Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients
Parkinson's Disease (PD)
Weill Medical College of Cornell University40 enrolled1 locationNCT06975059
Recruiting
Phase 2
Rehabilitation of Airway Protection in Parkinson's Disease
Parkinson DiseaseDysphagia
Teachers College, Columbia University120 enrolled2 locationsNCT05700825
Recruiting
Autoimmune Features of Neurodegenerative Disorders
Alzheimer DiseaseParkinson DiseaseMild Cognitive Impairment
Columbia University120 enrolled1 locationNCT04239079
Recruiting
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Disease
Parkinson's Foundation25,000 enrolled56 locationsNCT04994015
Recruiting
NYSCF Scientific Discovery Biobank
Ovarian CancerCervical CancerDiabetes Mellitus+26 more
New York Stem Cell Foundation Research Institute10,000 enrolled1 locationNCT06203106
Recruiting
Drug Discovery for Parkinson's With Mutations in the GBA Gene
HealthyGaucher DiseaseParkinson Disease+1 more
New York Stem Cell Foundation Research Institute60 enrolled1 locationNCT05536388
Recruiting
Early Phase 1
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
Parkinson Disease
Teachers College, Columbia University42 enrolled1 locationNCT06540989